Home > Healthcare > Drug Device Combination > Therapeutic Systems > Surgical Hemostats Market
Surgical Hemostats Market Share
- Report ID: GMI7748
- Published Date: Dec 2023
- Report Format: PDF
Surgical Hemostats Market Share
The surgical hemostats industry is consolidated, with key players including Medtronic Plc, Ethicon, Inc. (Johnson & Johnson), Baxter International Inc., Teleflex Corporation, Pfizer, Inc., and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, in September 2022, Medtronic plc announced U.S. FDA clearance for its Nexpowder endoscopic hemostasis system. This system is developed by Nextbiomedical CO., LTD and distributed by Medtronic. Additionally, this system is designed to address upper gastrointestinal nonvariceal bleeding, a common medical issue that accounts for a significant portion of acute gastrointestinal (GI) bleeding cases. Such product approvals help companies to strengthen its product offerings and generate significant revenue.
Surgical Hemostats Market Companies
Some of the eminent market participants operating in the surgical hemostats industry include:
- Becton, Dickinson and Company
- Medtronic plc
- Teleflex Corporation
- Baxter International Inc.
- B. Braun Melsungen AG
- Pfizer, Inc.
- Ethicon, Inc. (Johnson & Johnson)
- Stryker Corporation
- CuraMedical BV
- Gelita Medical GmbH
- Integra LifeSciences
- Marine Polymer Technologies, Inc
- Hemostasis LLC
Frequently Asked Questions (FAQ) :
Surgical Hemostats Market Scope
